--2025/Q1-- / 1.197M--
--2024/Q4-- / 1.567M--
--2024/Q33.074M / 1.445M--
--2024/Q26.772M / 1.548M--
May 9, 20242024/Q11.925M / 1.260M--
Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
FATE Fate Therapeutics
- 1.670
- -0.080-4.57%
Close Jan 8 16:00 ET
- 1.680
- +0.010+0.60%
Post 19:50 ET
190.20MMarket Cap-1.02P/E (TTM)
1.750High1.630Low1.69MVolume1.730Open1.750Pre Close2.82MTurnover1.70%Turnover RatioLossP/E (Static)113.89MShares8.83052wk High0.52P/B165.45MFloat Cap1.55052wk Low--Dividend TTM99.07MShs Float121.160Historical High--Div YieldTTM6.86%Amplitude1.460Historical Low1.671Avg Price1Lot Size
Fate Therapeutics Key Stats
Fate Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Fate Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data